Deep Dive on R&D | pharmaphorum

Deep Dive

R&D

The many trends reshaping clinical trials: An interview with...

Over the last five years, a confluence of trends have combined to reshape the reality of clinical research. COVID-19 pushed decentralised trials into the mainstream.

R&D

Heard on the pipeline hexagon graphical banner

Heard on the pipeline: AI in R&D

As has become tradition in the pharma and biotech world, 2024 kicked off with a bang as experts from around the globe gathered in San Francisco for the 42nd annual JP Morgan Health Conferen

R&D

Accelerating innovation in rare diseases

Millions of people living with rare diseases are urgently waiting for diagnosis, care, and life-changing treatment options.

R&D

Decoding life: Key milestones in the CRISPR odyssey

The story of CRISPR’s development, from its humble beginnings as a bacterial defence mechanism to its current status as a groundbreaking tool for gene editing and beyond, is a fascinating j

R&D

Setting the standard for sustainability in pharma

Sustainability has become a crucial pillar in pharmaceutical development, with environmental concerns and resource management demanding immediate attention from organisations of all sizes a

R&D

The backbone of breakthroughs: Insights into clinical trial ...

Behind every successfully approved treatment lies a nexus of clinical research activities comprising myriad drug types, trial phases, and packaging needs across diverse geographical locatio